Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SchistoShield Vaccine Against Schistosoma mansoni Infection
NCT05999825Phase 2Unknown
- Sponsor
- Leiden University Medical Center
- Start
- Sep 2024
- Primary completion
- Apr 2025
- Modality
- Recombinant Proteins and Enzymes, Vaccines & Immunotherapeutics
01
Overview
A Phase 2 trial of SchistoShield in schistosomiasis, sponsored by Leiden University Medical Center. Status: unknown.
02
Drugs
SchistoShield
03
Conditions
schistosomiasis
Beyond the preview
Go deeper on NCT05999825.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05999825.